News and Announcements
OncoSil US FDA Investigational Device Exemption Submitted
- Published December 14, 2015 12:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th December 2015, ASX Announcement
OncoSil Medical Lmited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce that it has filed an Investigational Device Exemption (IDE) with the US Food and Drug Administration (FDA) for its lead product candidate, the OncoSilTM localised radiation treatment for cancer.
This is a significant milestone in the development pathway for OncoSilTM in pancreatic cancer and is the firsts step towards securing FDA commercial approval for OncoSilTM under a Pre-market Appoval (PMA).
Subject to an IDE being granted, OncoSil Medical will commence a clinical study under the FDA to support the PMA. A PMA will allow the Company to commercially market OncoSilTM in the USA.
The company formally filed its IDE submission on 10th December 2015 after successfully completing a lengthy pre-IDE process. The pre-IDE process involved an FDA review of the proposed Clinical Investigational plan including the endorsement of clinical endpoints and outcomes measure.
To read the full announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
